Unknown

Dataset Information

0

Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats.


ABSTRACT: Chalcone-1-deoxynojirimycin heterozygote (DC-5), a novel compound which was designed and synthesized in our laboratory for diabetes treatment, showed an extremely strong in vitro inhibitory activity on α-glucosidase in our previous studies. In the current research, its potential in vivo anti-diabetic effects were further investigated by integration detection and the analysis of blood glucose concentration, blood biochemical parameters, tissue section and gut microbiota of the diabetic rats. The results indicated that oral administration of DC-5 significantly reduced the fasting blood glucose and postprandial blood glucose, both in diabetic and normal rats; meanwhile, it alleviated the adverse symptoms of elevated blood lipid level and lipid metabolism disorder in diabetic rats. Furthermore, DC-5 effectively decreased the organ coefficient and alleviated the pathological changes of the liver, kidney and small intestine of the diabetic rats at the same time. Moreover, the results of 16S rDNA gene sequencing analysis suggested that DC-5 significantly increased the ratio of Firmicutes to Bacteroidetes and improved the disorder of gut microbiota in diabetic rats. In conclusion, DC-5 displayed a good therapeutic effect on the diabetic rats, and therefore had a good application prospect in hypoglycemic drugs and foods.

SUBMITTER: Xiao PJ 

PROVIDER: S-EPMC9658082 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chalcone-1-Deoxynojirimycin Heterozygote Reduced the Blood Glucose Concentration and Alleviated the Adverse Symptoms and Intestinal Flora Disorder of Diabetes Mellitus Rats.

Xiao Pin-Jian PJ   Zeng Jia-Cheng JC   Lin Ping P   Tang Dao-Bang DB   Yuan En E   Tu Yong-Gang YG   Zhang Qing-Feng QF   Chen Ji-Guang JG   Peng Da-Yong DY   Yin Zhong-Ping ZP  

Molecules (Basel, Switzerland) 20221104 21


Chalcone-1-deoxynojirimycin heterozygote (DC-5), a novel compound which was designed and synthesized in our laboratory for diabetes treatment, showed an extremely strong in vitro inhibitory activity on α-glucosidase in our previous studies. In the current research, its potential in vivo anti-diabetic effects were further investigated by integration detection and the analysis of blood glucose concentration, blood biochemical parameters, tissue section and gut microbiota of the diabetic rats. The  ...[more]

Similar Datasets

| S-EPMC9268590 | biostudies-literature
| S-EPMC10288885 | biostudies-literature
| PRJNA1206528 | ENA
| PRJNA1098963 | ENA
| PRJNA306395 | ENA
| PRJNA743690 | ENA
| S-EPMC9852891 | biostudies-literature
| S-BSST1338 | biostudies-other
| S-EPMC8556111 | biostudies-literature
| PRJNA777109 | ENA